BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4192155)

  • 1. Properties of structurally restricted antibody to type VIII pneumococcal polysaccharide.
    Pincus JH; Jaton JC; Bloch KJ; Haber E
    J Immunol; 1970 May; 104(5):1149-54. PubMed ID: 4192155
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies of restricted heterogeneity for structural study.
    Haber E
    Fed Proc; 1970; 29(1):66-71. PubMed ID: 4391650
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to type III and type VIII pneumococcal polysaccharides: evidence for restricted structural heterogeneity in hyperimmunized rabbits.
    Pincus JH; Jaton JC; Bloch KJ; Haber E
    J Immunol; 1970 May; 104(5):1143-8. PubMed ID: 4192154
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistence and characterization of idiotypes in pedigreed rabbits producing antibodies of restricted heterogeneity to pneumococcal polysaccharides.
    Winfield JB; Pincus JH; Mage RG
    J Immunol; 1972 May; 108(5):1278-87. PubMed ID: 4112921
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.
    Baker PJ; Prescott B; Stashak PW; Amsbaugh DF
    J Immunol; 1971 Sep; 107(3):719-24. PubMed ID: 4398381
    [No Abstract]   [Full Text] [Related]  

  • 6. Treadmill neutralization of antibody and central inhibition. Separate components of pneumococcal polysaccharide paralysis.
    Howard JG; Christie GH; Courtenay BM
    Transplantation; 1970 Oct; 10(4):251-3. PubMed ID: 4396243
    [No Abstract]   [Full Text] [Related]  

  • 7. A familial incidence of structurally restricted antibodies to pneumococcal polysaccharides.
    Pincus JH; Mage RG; Alexander C; Chace NM
    Eur J Immunol; 1973 Jul; 3(7):435-41. PubMed ID: 4148479
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    Immunology; 1971 Apr; 20(4):481-92. PubMed ID: 4396489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of immune and natural specific antibodies in immunologic paralysis and immunity of mice to pneumococcal polysaccharide type 3.
    Kerman R; Segre D; Myers WL
    J Immunol; 1970 Mar; 104(3):656-64. PubMed ID: 4190969
    [No Abstract]   [Full Text] [Related]  

  • 10. Morphology of the antibody response to pneumococcal polysaccharide in mice.
    Hajdu I
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):226-34. PubMed ID: 43878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B; Barth RF
    J Immunol; 1970 Dec; 105(6):1581-3. PubMed ID: 4394909
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of hyperimmune restricted and partially restricted anti-pneumococcal polysaccharide antibodies from allotype-defined pedigreed rabbits. I. Preparative liquid isoelectric focusing of the antibodies and characterization of the isolated fractions by electrophoretic techniques.
    Freedman MH; Pincus JH; Yeger H; McKenney JA; Mage RG
    Eur J Immunol; 1974 Aug; 4(8):553-60. PubMed ID: 4153482
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    J Immunol; 1974 Jan; 112(1):404-9. PubMed ID: 4149590
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental approaches to homogenous antibody populations. Mouse IgA myeloma proteins that bind polysaccharide antigens of enterobacterial origin.
    Potter M
    Fed Proc; 1970; 29(1):85-91. PubMed ID: 4983816
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmented anti-S 3 antibody responses to an S 3 -protein conjugate.
    Paul WE; Katz DH; Benacerraf B
    J Immunol; 1971 Sep; 107(3):685-8. PubMed ID: 4105931
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum.
    Baker PJ; Barth RF; Stashak PW; Amsbaugh DF
    J Immunol; 1970 May; 104(5):1313-5. PubMed ID: 4392713
    [No Abstract]   [Full Text] [Related]  

  • 17. The response in rabbits to prolonged immunization with type 3 pneumococci.
    Kimball JW; Pappenheimer AM; Jaton JC
    J Immunol; 1971 May; 106(5):1177-84. PubMed ID: 4396843
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody formation by spleen cells of immunologically tolerant mice stimulated with antigen-antibody complexes.
    Intini C; Segre D; Segre M; Myers WL
    J Immunol; 1971 Oct; 107(4):1014-21. PubMed ID: 4398437
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune paralysis induced by pneumococcal polysaccharide. II. Studies with peritoneal and spleen cell extracts and RNA.
    Williams CC; Wu WG
    J Immunol; 1971 Jul; 107(1):163-71. PubMed ID: 4397493
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolution of the immune response to type 3 and 8 pneumococcal polysaccharides.
    Chen FW; Strosberg AD; Haber E
    J Immunol; 1973 Jan; 110(1):98-106. PubMed ID: 4405516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.